DE60111520D1 - Hydroxyphenyl-piperazinyl-methyl-benzamid-derivate zur schmerzbehandlung - Google Patents

Hydroxyphenyl-piperazinyl-methyl-benzamid-derivate zur schmerzbehandlung

Info

Publication number
DE60111520D1
DE60111520D1 DE60111520T DE60111520T DE60111520D1 DE 60111520 D1 DE60111520 D1 DE 60111520D1 DE 60111520 T DE60111520 T DE 60111520T DE 60111520 T DE60111520 T DE 60111520T DE 60111520 D1 DE60111520 D1 DE 60111520D1
Authority
DE
Germany
Prior art keywords
piperazinyl
hydroxyphenyl
methyl
pain treatment
benzamide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60111520T
Other languages
English (en)
Other versions
DE60111520T2 (de
Inventor
William Brown
Niklas Plobeck
Christopher Walpole
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE60111520D1 publication Critical patent/DE60111520D1/de
Publication of DE60111520T2 publication Critical patent/DE60111520T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
DE60111520T 2000-04-04 2001-03-30 Hydroxyphenyl-piperazinyl-methyl-benzamid-derivate zur schmerzbehandlung Expired - Fee Related DE60111520T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0001209 2000-04-04
SE0001209A SE0001209D0 (sv) 2000-04-04 2000-04-04 Novel compounds
PCT/SE2001/000709 WO2001074805A1 (en) 2000-04-04 2001-03-30 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain

Publications (2)

Publication Number Publication Date
DE60111520D1 true DE60111520D1 (de) 2005-07-21
DE60111520T2 DE60111520T2 (de) 2006-05-11

Family

ID=20279148

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111520T Expired - Fee Related DE60111520T2 (de) 2000-04-04 2001-03-30 Hydroxyphenyl-piperazinyl-methyl-benzamid-derivate zur schmerzbehandlung

Country Status (24)

Country Link
US (1) US6696447B2 (de)
EP (1) EP1278740B1 (de)
JP (1) JP2003529597A (de)
KR (1) KR20020084284A (de)
CN (1) CN1422266A (de)
AR (1) AR033811A1 (de)
AT (1) ATE297914T1 (de)
AU (1) AU2001244983A1 (de)
BR (1) BR0109818A (de)
CA (1) CA2402705A1 (de)
CZ (1) CZ20023287A3 (de)
DE (1) DE60111520T2 (de)
EE (1) EE200200511A (de)
HU (1) HUP0300562A3 (de)
IL (1) IL151765A0 (de)
IS (1) IS6563A (de)
MX (1) MXPA02009758A (de)
NO (1) NO20024776L (de)
NZ (1) NZ521388A (de)
PL (1) PL357812A1 (de)
SE (1) SE0001209D0 (de)
SK (1) SK14262002A3 (de)
WO (1) WO2001074805A1 (de)
ZA (1) ZA200207381B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9504661D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE0100764D0 (sv) * 2001-03-07 2001-03-07 Astrazeneca Ab New assymetric process
KR100885100B1 (ko) * 2001-05-18 2009-02-20 아스트라제네카 아베 4(페닐-피페라지닐-메틸)벤즈아미드 유도체 및 통증,불안증 또는 위장관 장애 치료를 위한 이들의 용도
US8575169B2 (en) 2001-10-29 2013-11-05 Versi Group, Llc Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
US8476280B2 (en) 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0400027D0 (sv) * 2004-01-09 2004-01-09 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
SE0401968D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
KR101234421B1 (ko) * 2004-08-02 2013-02-18 아스트라제네카 아베 디아릴메틸 피페라진 유도체, 이의 제조 방법 및 용도
WO2006091160A1 (en) * 2005-02-28 2006-08-31 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
NZ590041A (en) * 2008-05-20 2012-11-30 Astrazeneca Ab Method of treating anxious major depressive disorder

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH583713A5 (de) 1973-06-29 1977-01-14 Cermol Sa
DE2900810A1 (de) 1979-01-11 1980-07-24 Cassella Ag Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung
IT1140978B (it) 1980-05-23 1986-10-10 Selvi & C Spa 1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche
GB8320701D0 (en) 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent
IT1196150B (it) 1984-06-19 1988-11-10 Poli Ind Chimica Spa Derivati di 1-(bis-(4-fluorofenil)metil)-4-(3-fenil-2-propenil)-esaidro-1h-1,4-diazepina ad attivita' calcio antagonista,sua preparazione e composizioni che lo contengono
SE8500573D0 (sv) 1985-02-08 1985-02-08 Ferrosan Ab Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US5028610A (en) 1987-03-18 1991-07-02 Sankyo Company Limited N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
US4829065A (en) 1987-04-24 1989-05-09 Syntex Pharmaceuticals, Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US4826844A (en) 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
RU2093156C1 (ru) 1989-11-22 1997-10-20 Жансен Фармасетика Н.В. L-(-)-2-(аминокарбонил)-n-(4-амино-2,6-дихлорфенил-4[5,5-бис(4-фторфенил)пентил]-1-пиперазинацетамид, его фармацевтически приемлемая кислотно-аддитивная соль или гидрат, способ его получения и средство для хранения сердца донора
US5574159A (en) 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
US5807858A (en) 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
US5681830A (en) 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
FR2696744B1 (fr) 1992-10-12 1994-12-30 Logeais Labor Jacques Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
HU221726B1 (hu) 1993-07-30 2002-12-28 Ardent Pharmaceuticals Inc. Piperazinszármazékok, e vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
JP3352184B2 (ja) 1993-11-12 2002-12-03 株式会社アズウェル ピペラジン不飽和脂肪酸誘導体
SE9504661D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
TW548271B (en) 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE9604786D0 (sv) 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
ATE306472T1 (de) * 1997-12-24 2005-10-15 Ortho Mcneil Pharm Inc (4)-(aryl(piperidin-4-yl) aminobenzamidderivate die an delta-opioid rezeptor binden
GB9804734D0 (en) * 1998-03-05 1998-04-29 Pfizer Ltd Compounds

Also Published As

Publication number Publication date
BR0109818A (pt) 2003-01-21
AR033811A1 (es) 2004-01-07
IS6563A (is) 2002-09-24
ATE297914T1 (de) 2005-07-15
MXPA02009758A (es) 2003-03-27
CN1422266A (zh) 2003-06-04
HUP0300562A3 (en) 2006-02-28
ZA200207381B (en) 2003-12-15
EE200200511A (et) 2004-02-16
NO20024776L (no) 2002-12-03
KR20020084284A (ko) 2002-11-04
SK14262002A3 (sk) 2003-05-02
EP1278740B1 (de) 2005-06-15
IL151765A0 (en) 2003-04-10
JP2003529597A (ja) 2003-10-07
AU2001244983A1 (en) 2001-10-15
DE60111520T2 (de) 2006-05-11
US20030139421A1 (en) 2003-07-24
SE0001209D0 (sv) 2000-04-04
NZ521388A (en) 2004-06-25
EP1278740A1 (de) 2003-01-29
WO2001074805A1 (en) 2001-10-11
CA2402705A1 (en) 2001-10-11
CZ20023287A3 (cs) 2003-03-12
HUP0300562A2 (hu) 2003-08-28
NO20024776D0 (no) 2002-10-03
US6696447B2 (en) 2004-02-24
PL357812A1 (en) 2004-07-26

Similar Documents

Publication Publication Date Title
PT1267650E (pt) Tratamento do tabaco
ATE358674T1 (de) 4-tetrazolyl-4-phenylpiperidindervate zur schmerzbehandlung
DK1335678T3 (da) Oralt behandlingssystem
AT6199U3 (de) Handgerät zur schmerzreduktion
DE60115874D1 (de) Instrument zur chirurgischen behandlung
DE60142565D1 (de) Mittel zur wasserbehandlung
FIU20060389U0 (fi) Luusairauksien hoito
ATE269324T1 (de) Hydroxyphenyl-piperidin-4-ylidene-methyl- benzamidderivate zur schmerzbekämpfung
FI20000863A (fi) Uusi hoitomenetelmä
FR2815535B1 (fr) Implant pediculaire
NO20032122L (no) Forbedret behandling
ATE297914T1 (de) Hydroxyphenyl-piperazinyl-methyl-benzamid- derivate zur schmerzbehandlung
ATE289603T1 (de) Chinolinyl-piperidin-4-yliden-methyl-benzamid- derivate zur schmerzbekämpfung
ATE250611T1 (de) Pyranoindole zur glaukombehandlung
DE60221068D1 (de) Gerät zur tiefenwirksamen Hauttherapie
DE60131665D1 (de) Vorrichtung zur mikrostromtherapie
IS6626A (is) Kristallskenndur meðferðarmiðill
ATA11452000A (de) Vorrichtung zur körperpflege
ATE285468T1 (de) Gewebehandlungszubereitung
FI20002756A0 (fi) Uusi hoitomenetelmä
SE9903421D0 (sv) Behandlingsförfarande
FI20002229A (fi) Menetelmä selkäkivun hoitamiseksi
DK1286986T3 (da) Quinolinylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerte

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee